Drug/Small Molecule:
norethindrone

2D structure

Overview

Trade Names: Anhydrohydroxynorprogesterone; Anovulatorio; Anovule; Aygestin; Binovum; Brevicon; Brevinor; Brevinor 21; Brevinor 28; Brevinor-1 21; Brevinor-1 28; Camila; Ciclovulan; Conceplan; Conludaf; Conludag; Demulen; ENT; Errin; Estrinor; Ethinylnortestosterone; Ethynylmortestosterone; Ethynylnortestosterone; Gencept; Genora; Gestest; Jenest; Jenest-28; Loestrin; Menzol; Microneth; Micronett; Micronor; Micronovum; Milli; Mini-Pe; Mini-Pill; Minovlar; Modicon; N.E.E.; NET; Necon; Nelova; Neocon; Nodiol; Nor-Q.D.; Nor-Qd; Noraethisteronum; Noralutin; Norcept; Norcept-E; Norcolut; Noresthisterone; Norethadrone; Norethin; Norethin 1/35 E; Norethin 1/50 M; Norethindrone Acetate; Norethindrone Norethisterone; Norethisteron; Norethisterone; Norethisterone [Progestins]; Norethisteronum [INN-Latin]; Norethyndron; Norethynodron; Norethynodrone; Noretisterona [INN-Spanish]; Noretisterone [Dcit]; Norfor; Norgestin; Noriday; Noriday 28; Norimin; Norinyl; Norlestrin; Norlutate; Norluten; Norlutin; Norluton; Normapause; Norpregneninlone; Norpregneninolone; Norpregneninotone; Orlest; Ortho 1 35; Ortho 7 7 7; Ortho-Novum; Ortho-Novum 1 35; Ortho-Novum 1 50; Ortho-Novum 7 7 7; Ovcon; Ovysmen; Ovysmen 0.5 35; Ovysmen 1 35; Palonyl; Perovex; Primolut N; Primolut-N; Proluteasi; Synphase; Synphasic 28; Tri-Norinyl; Triella; Trinovum; Trinovum 21; Utovlan; Utovlar
Brand Mixtures: Brevicon 0.5/35 21 Tab (Ethinyl Estradiol + Norethindrone); Brevicon 0.5/35 28 Tab (Ethinyl Estradiol + Norethindrone); Brevicon 0.5/35 Tablets (21-Day Pack) (Ethinyl Estradiol + Norethindrone); Brevicon 0.5/35 Tablets (28-Day Pack) (Ethinyl Estradiol + Norethindrone); Brevicon 1/35 21 Tab (Ethinyl Estradiol + Norethindrone); Brevicon 1/35 28 Tab (Ethinyl Estradiol + Norethindrone); Brevicon 1/35 Tablets (21-Day Pack) (Ethinyl Estradiol + Norethindrone); Brevicon 1/35 Tablets (28-Day Pack) (Ethinyl Estradiol + Norethindrone); Estalis 140/50 Mcg (Estradiol + Norethindrone Acetate); Estalis 250/50 Mcg (Estradiol + Norethindrone Acetate); Estalis Sequi (Estradiol + Norethindrone Acetate); Estracomb (Estradiol + Norethindrone Acetate); Femhrt 1/5 (Ethinyl Estradiol + Norethindrone Acetate); Loestrin 1.5/30 21day Pak (Ethinyl Estradiol + Norethindrone Acetate); Loestrin 1.5/30 28day Pack (Ethinyl Estradiol + Norethindrone Acetate); Minestrin 1/20 21 (Ethinyl Estradiol + Norethindrone Acetate); Minestrin 1/20 28 (Ethinyl Estradiol + Norethindrone Acetate); Norinyl 1/50 - (21-Day Regimen) (Mestranol + Norethindrone); Norinyl 1/50 - (28-Day Regimen) (Mestranol + Norethindrone); Norinyl 1/50 21 Tab (Mestranol + Norethindrone); Norinyl 1/50 28 Tab (Mestranol + Norethindrone); Ortho 0.5/35 Tablets (21 Day) (Ethinyl Estradiol + Norethindrone); Ortho 0.5/35 Tablets (28day) (Ethinyl Estradiol + Norethindrone); Ortho 1/35 Tablets (21 Day) (Ethinyl Estradiol + Norethindrone); Ortho 1/35 Tablets (28 Day) (Ethinyl Estradiol + Norethindrone); Ortho 10/11 Tablets (21 Day) (Ethinyl Estradiol + Norethindrone); Ortho 10/11 Tablets (28 Day) (Ethinyl Estradiol + Norethindrone); Ortho 7/7/7 Tablets (21 Day) (Ethinyl Estradiol + Norethindrone); Ortho 7/7/7 Tablets (28 Day) (Ethinyl Estradiol + Norethindrone); Ortho-Novum 1/50 Tablets (21 Day) (Mestranol + Norethindrone); Ortho-Novum 1/50 Tablets (28 Day) (Mestranol + Norethindrone); Select 1/35 (21-Day) (Ethinyl Estradiol + Norethindrone); Select 1/35 (28-Day) (Ethinyl Estradiol + Norethindrone); Synphasic 21 Tablets (Ethinyl Estradiol + Norethindrone); Synphasic 28 Tablets (Ethinyl Estradiol + Norethindrone); Synphasic-28 Tablets (Ethinyl Estradiol + Norethindrone)
PharmGKB Accession Id: PA450651

Description

A synthetic progestational hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. PubChem (source: Drug Bank)

Indication

For use as an oral contraceptive in the prevention of pregnancy. (source: Drug Bank)

ATC Therapeutic Category

  • G03AC:Progestogens

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Progestins diffuse freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge. (source: Drug Bank)

Pharmacology

Norethindrone is a synthetic oral progestin. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. As an oral contraceptive, norethindrone is available as either a single agent or in combination with an estrogen. (source: Drug Bank)

Food Interactions

Take without regard to meals. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic (source: Drug Bank)

Protein Binding

>95% (source: Drug Bank)

Absorption

Absolute oral bioavailability approximately 64% (source: Drug Bank)

Isomeric SMILES Code:

C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34 (source: Drug Bank)

The following genes are in curated knowledge about this drug.

  Gene Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
F2
  • CO
  • PD
  •   
  •   
  •   
Publications

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
PGR Uncurated Annotation (source: Drug Bank)
SHBG Uncurated Annotation (source: Drug Bank)

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
acitretin Uncurated Annotation Acitretine may cause a loss of contraceptive effect (source: Drug Bank)
amobarbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
bosentan Uncurated Annotation Bosentan decreases the effect of the contraceptive (source: Drug Bank)
butalbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
carbamazepine Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
griseofulvin Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
hexobarbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
lamotrigine Uncurated Annotation The oral contraceptive decreases the effect of lamotrigine (source: Drug Bank)
mephenytoin Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
methylphenobarbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
pentobarbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
phenobarbital Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
phenytoin Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
pioglitazone Uncurated Annotation Possible loss of contraceptive effect (source: Drug Bank)
primidone Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
rifabutin Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
rifampin Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
tizanidine Uncurated Annotation The contraceptive increases the effect of tizanidine (source: Drug Bank)
troglitazone Uncurated Annotation Possible loss of contraceptive effect (source: Drug Bank)

Curated Information

The following diseases are in curated knowledge about this drug.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Colorectal Neoplasms
  • CO
  •   
  •   
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Thrombosis of cerebral veins
  • CO
  • PD
  •   
  •   
  •   
Publications

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00717
KEGG Compound ID:
C05028
KEGG Drug ID:
D00182
PubChem Compound ID:
6230
PubChem Substance ID:
7847250

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.